Paolo Ubiali Selected Research

Interleukin-2 (IL2)

1/2019

Cyclophosphamide with or without fluorouracil followed by subcutaneous or intravenous interleukin-2 use in solid tumors: A feasibility off-label experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paolo Ubiali Research Topics

Disease

3	Neoplasms (Cancer) 01/2021 - 01/2019
2	Stomach Neoplasms (Stomach Cancer) 11/2023 - 06/2023
1	Anastomotic Leak 11/2023
1	Solitary Fibrous Tumors 01/2023
1	Malignant Pleural Effusion 10/2020
1	Neoplasm Metastasis (Metastasis) 10/2020
1	Carcinoma (Carcinomatosis) 09/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Cholecystitis 04/2002

Drug/Important Bio-Agent (IBA)

1	C-PeptideIBA 01/2023
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2023
1	Insulin (Novolin)FDA Link 01/2023
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2020
1	Carcinoembryonic AntigenIBA 10/2020
1	C-Reactive ProteinIBA 10/2020
1	Interleukin-2 (IL2)IBA 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	Phenobarbital (Luminal)FDA Link 01/2018

Therapy/Procedure

1	Gastroenterostomy 11/2023
1	Gastrectomy 11/2023
1	Minimally Invasive Surgical Procedures 06/2023
1	Radiotherapy 01/2021
1	Adrenalectomy 09/2018
1	Laparoscopic Cholecystectomy 04/2002